Mast cells regulate procollagen I (alpha 1) production by bronchial fibroblasts derived from subjects with asthma through IL-4/IL-4 delta 2 ratio

J Allergy Clin Immunol. 2006 Jun;117(6):1321-7. doi: 10.1016/j.jaci.2005.12.1349. Epub 2006 Feb 21.

Abstract

Background: Asthma is characterized by inflammation and remodeling. Mast cells are generally increased in bronchial mucosa of subjects with asthma. These cells release a wide variety of cytokines and mediators that have the capacity to stimulate other resident cells such as smooth muscle cells and fibroblasts.

Objective: This study was designed to evaluate whether mast cells modulate collagen production by bronchial fibroblasts isolated from subjects with asthma and normal subjects through cytokine production.

Methods: Human mast cells were cocultured for 72 hours with primary bronchial fibroblasts isolated from bronchial biopsies of subjects with mild asthma and normal controls. Procollagen I (alpha1), IL-4Ralpha, IL-13Ralpha1, and IL-13Ralpha2 gene expression by bronchial fibroblasts and IL-4 and IL-4delta2 gene expression by mast cells were quantified by real-time RT-PCR. IL-4 production was also measured by ELISA in culture supernatants.

Results: Procollagen I (alpha1) gene expression by fibroblasts from subjects with asthma was significantly higher compared with cells from normal controls when cocultured with mast cells. Mast cells expressed IL-4 isoform and IL-4delta2, an alternative splice variant of IL-4. Coculture significantly increased the expression of IL-4 but not IL-4delta2 by mast cells when they were cultured with fibroblasts from subjects with asthma compared with cells from normal controls. Neutralization of IL-4 abrogated collagen mRNA expression. There was no significant change in IL-4Ralpha or IL-13Ralpha1. However, IL-13Ralpha2 gene expression was significantly reduced in fibroblasts from subjects with asthma.

Conclusion: These results suggest that inflammatory process may regulate airway remodelling through crosstalk between inflammatory and structural cells. Targeting this crosstalk may have therapeutic application.

Clinical implications: Understanding mechanisms that govern airway remodeling and collagen deposition in asthma is a step toward therapeutic management of this disease. In this work, we found that mast cell-fibroblast crosstalk may be a potential future target to control some aspects of airway remodeling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternative Splicing / genetics
  • Asthma / metabolism*
  • Asthma / pathology
  • Cell Line, Tumor
  • Coculture Techniques
  • Collagen Type I / antagonists & inhibitors
  • Collagen Type I / biosynthesis*
  • Collagen Type I / genetics
  • Collagen Type I, alpha 1 Chain
  • Fibroblasts / immunology
  • Fibroblasts / metabolism*
  • Fibroblasts / pathology
  • Humans
  • Interleukin-13 Receptor alpha1 Subunit
  • Interleukin-4 / metabolism*
  • Mast Cells / immunology*
  • Protein Isoforms / antagonists & inhibitors
  • Protein Isoforms / biosynthesis*
  • Protein Isoforms / genetics
  • RNA, Messenger / antagonists & inhibitors
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Receptors, Interleukin / metabolism
  • Receptors, Interleukin-13

Substances

  • Collagen Type I
  • Collagen Type I, alpha 1 Chain
  • IL13RA1 protein, human
  • IL4 protein, human
  • Interleukin-13 Receptor alpha1 Subunit
  • Protein Isoforms
  • RNA, Messenger
  • Receptors, Interleukin
  • Receptors, Interleukin-13
  • Interleukin-4